In the intricate world of pharmaceutical research and manufacturing, certain chemical compounds serve as indispensable building blocks that enable the creation of life-saving medicines. 2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one, readily identified by its CAS number 20348-21-4, is one such critical compound. This pharmaceutical intermediate is characterized by its specific molecular structure and high purity, making it a cornerstone for many complex synthesis processes.

With a molecular formula of C9H10N2O2 and a molecular weight of 178.18800, CAS 20348-21-4 presents itself typically as a white powder. Its physical and chemical properties, including a density of 1.176 g/cm³ and a high boiling point of 352.5°C, underscore its stability and suitability for demanding chemical reactions. The purity level, often at or above 98.0%, is a non-negotiable aspect for pharmaceutical applications, ensuring that the compound acts as a reliable chemical building block without introducing unwanted contaminants into the synthesis chain.

The primary utility of 2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one lies in its role as a pharmaceutical intermediate. It is instrumental in the multi-step synthesis of Active Pharmaceutical Ingredients (APIs), contributing to the development of therapies for various medical conditions. For researchers and manufacturers aiming to buy 2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one, NINGBO INNO PHARMCHEM CO.,LTD. serves as a premier supplier. We ensure that our product meets stringent quality standards, offering consistency and reliability essential for reproducible research and efficient manufacturing.

Understanding the significance of compounds like CAS 20348-21-4 is vital for the progress of pharmaceutical innovation. By providing a dependable source for this key intermediate, we support the efforts of scientists and manufacturers in their quest to develop novel drugs. The commitment to quality, from production to storage, ensures that this essential chemical building block remains a trusted component in the pharmaceutical supply chain, facilitating advancements in healthcare.